MANAGEMENT OF LOCALIZED AND LOCALLY ADVANCED ENDOMETRIAL CANCERS IN 2025: THE PLACE OF RADIOTHERAPY AND BRACHYTHERAPY

Authors

  • Dr. Nicolas VIAL CHU de Saint-Etienne, 108 bis avenue Albert Raimond, 42270 Saint-Priest-en-Jarez.

DOI:

https://doi.org/10.54695/cf.004.1.0017

Keywords:

endometrial cancers, molecular biology, 2023 FIGO classification, ESGO-ESMO-ESP 2021 consen sus, pelvis external beam radiotherapy, vaginal brachytherapy.

Abstract

The current value of molecular biology data allowed to introduce a new characterization for localized and locally advanced endometrial cancers. In the same time, the FIGO staging has been recently updated.
Their incorporation into practice recommandations defined by ESGO-ESMO-ESP 2021 should more specify risk levels associated with each oncological situation, and therefore more precise indications of adjuvant therapies such as radiotherapy and/or brachytherapy.

Author Biography

Dr. Nicolas VIAL, CHU de Saint-Etienne, 108 bis avenue Albert Raimond, 42270 Saint-Priest-en-Jarez.

Oncologue - Radiothérapeute. Département de Radiothérapie,

Published

2025-07-31

How to Cite

VIAL, D. N. . (2025). MANAGEMENT OF LOCALIZED AND LOCALLY ADVANCED ENDOMETRIAL CANCERS IN 2025: THE PLACE OF RADIOTHERAPY AND BRACHYTHERAPY. Cancers Au Féminin, Actualités Permanentes En Senologie , (1), 17 - 26. https://doi.org/10.54695/cf.004.1.0017

Issue

No. 1 (2025): CANCERS AU FÉMININ

Section

Articles